A Study to Evaluate Comparative Bioavailability of BMS-986278 in Healthy Participants

Completed · Phase 1

Conditions studied: Healthy Volunteers

In brief

This is a trial to evaluate the comparative bioavailability of BMS-986278 to-be-marketed formulation compared to the phase 3 clinical trial formulation in healthy participants.

Key facts

Study ID
NCT06715683
Run by
Bristol-Myers Squibb
People needed
48
Starts
2024-12-12
Expected to finish
2025-03-16
Last updated by the study team
2025-04-04

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.